Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms

NCT05587361 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05587361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms
Lead sponsor
University of Oklahoma
Phase
Phase 4
Overall status
Recruiting
Start date
November 26, 2024
Completion date
March 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking, nicotine dependence, tobacco use disorder